European Primary Care Cardiovascular Society

COVID-19

During COVID-19 pandemic in USA, there was a decrease in primary care visits, but increase in telemedicine

Literature - Oct. 13, 2020 - Alexander GC, et al. - JAMA Netw Open. 2020

Changes in the structure of primary care delivery, and differences in content of telemedicine visits vs. office-based visits were observed in the USA during the COVID-19 pandemic.

Temporarily suspending or continuing ACEi/ARBs in hospitalized patients with COVID-19

3' education - Sep. 30, 2020 - Prof. Renato D. Lopes, MD, PhD
BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

ESC 2020 BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

Continuing versus suspending ACEi and ARBs in COVID-19

News - Sep. 9, 2020

ESC 2020 Suspension of ACEi/ARB therapy for 30 days did not impact the number of days alive and out of hospital at 30 days compared to continued use of these medications in COVID-19 patients.

Recovered COVID-19 patients and cardiac abnormalities

3' education - Aug. 19, 2020 - Prof. Rudolf de Boer, MD, PhD
Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Ongoing myocardial inflammation and cardiac involvement in recovered COVID-19 patients

Literature - July 30, 2020 - Puntmann VO et al., - JAMA Cardiol. 2020.

Cardiovascular MRI revealed cardiac involvement in 78% of patients and ongoing myocardial inflammation in 60% of patients in an unselected cohort of 100 patients who recently recovered from COVID-19.

Decrease in STEMI admissions reported by health professionals since COVID-19 outbreak

Literature - July 14, 2020 - Pessoa-Amorim G et al., - Eur Heart J Qual Care Clin Outcomes. 2020.

A survey conducted by the ESC among cardiologists and CV nurses revealed that 78.8% of responders perceived a decrease in STEMI admissions since the beginning of the COVID-19 outbreak.

More out-of-hospital cardiac arrest during COVID-19 outbreak in Lombardy, Italy

3' education - June 18, 2020 - Enrico Baldi, MD
There was a 58% increase in out-of-hospital cardiac arrest during the inital phase of the COVID-19 outbreak in the Lombardia region in Italy compared to the same period in 2019. Watch a video on the study by Baldi and colleagues.

Out-of-hospital cardiac arrest during the inital phase of the COVID-19 outbreak was substantially increased in the Lombardia region in Italy compared to the same period in 2019. Baldi briefly presents the details and outcomes of a study.

Issues of CV risk management in diabetes patients during the COVID-19 era

News - June 2, 2020

Members of the Diabetes and Cardiovascular Disease EASD Study Group have published a perspective on issues of CV risk management in diabetes patients during the COVID-19 pandemic.

No harm of ARBs/ACEi in COVID-19 patients, demonstrated in three studies

News - June 2, 2020
Recently, three papers were published in the N Engl J Med on the effect of ACE inhibitors and (ARBs in patients with COVID-19, which all three showed no evidence that ACE inhibitors or ARBs affect the risk of COVID-19

Recently, three papers were published in the N Engl J Med on the effect of ACE inhibitors and (ARBs in patients with COVID-19, which all three showed no evidence that ACE inhibitors or ARBs affect the risk of COVID-19

High incidence of acute kidney injury in COVID-19 patients

Literature - May 28, 2020 - Hirsch JS et al., - Kidney Int. 2020.

This study showed that 36.3% of patients hospitalized with COVID-19 developed acute kidney injury during hospitalization.

Coagulopathy in COVID-19

Literature - May 28, 2020 - Levi M et al., - Lancet Haematol. 2020.

This comment article describes characteristics of coagulopathy in patients with COVID-19 and discusses recommendations for the therapeutic management of COVID-19-associated coagulopathy.

Management of diabetes during COVID-19 pandemic - practical recommendations

News - May 19, 2020

A consensus document by a group of representatives from primary and secondary care has been published on the management of diabetes for patients at risk or with confirmed COVID-19.

COVID-19